Glucocorticoid sensitivity in inflammatory bowel disease

References

• Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;4947:1041–8.
   Google Scholar
• Benchimol EI, Seow CH, Steinhart AH, Griffiths AM. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008;2: CD006792.
   PubMedGoogle Scholar
• Truelove SC, Willoughby CP, Lee EG, Kettlewell MG. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet. 1978;2:1086–8.
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994;35:360–2.
   PubMed Web of Science ®Google Scholar
• Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255–60.
   PubMed Web of Science ®Google Scholar
• Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96:23–43.
   PubMed Web of Science ®Google Scholar
• Teshima C, Fedorak RN. Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment? Inflamm Bowel Dis. 2008;14 (Suppl 2):S216–8.
   Google Scholar
• Rang HP, Dale MM, Ritter JM, Flower R. Rang and Dale's Pharmacology. 6th. Edinburgh: Churchill Livingstone; 2007.
   Google Scholar
• Edsbacker S, Andersson T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin Pharmacokinet. 2004;43:803–21.
   PubMed Web of Science ®Google Scholar
• Baron JH, Connell AM, Kanaghinis TG, Lennard-Jones JE, Jones AF. Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone. Br Med J. 1962;5302:441–3.
   Google Scholar
• Rutgeerts PJ. Review article: the limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther. 2001; 15:1515–25.
   PubMed Web of Science ®Google Scholar
• Friend DR. Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 1998;12: 591–603.
   PubMed Web of Science ®Google Scholar
• Seow CH, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008;3: CD000296.
   Google Scholar
• Turner D, Walsh CM, Benchimol EI, Mann EH, Thomas KE, Chow C, . Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut. 2008;57:331–8.
   PubMed Web of Science ®Google Scholar
• Dinesen LC, Walsh AJ, Protic MN, Heap G, Cummings F, Warren BF, . The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431–7.
   PubMed Web of Science ®Google Scholar
• Frey BM, Frey FJ. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet. 1990;19: 126–46.
   PubMed Web of Science ®Google Scholar
• Schwab M, Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet. 2001;40:723–51.
   PubMed Web of Science ®Google Scholar
• Zbankova S, Bryndova J, Leden P, Kment M, Svec A, Pacha J. 11beta-Hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis. J Gastroenterol Hepatol. 2007;22:1019–23.
   PubMed Web of Science ®Google Scholar
• Stegk JP, Ebert B, Martin HJ, Maser E. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases. Mol Cell Endocrinol. 2009;301:104–8.
   PubMed Web of Science ®Google Scholar
• Farrell RJ, Murphy A, Long A, Donnelly S, Cherikuri A, O’Toole D, . High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 2000;118:279–88.
   PubMed Web of Science ®Google Scholar
• Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol. 2006; 12:3636–44.
   PubMed Web of Science ®Google Scholar
• Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol. 2006;102:11–21.
   PubMed Web of Science ®Google Scholar
• Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell. 1999;97:161–3.
   PubMed Web of Science ®Google Scholar
• Francke U, Foellmer BE. The glucocorticoid receptor gene is in 5q31-q32 [corrected]. Genomics. 1989;4:610–2.
   PubMed Web of Science ®Google Scholar
• Turner JD, Muller CP. Structure of the glucocorticoid recetor (NR3C1) gene 5’ untranslated region: identification, and tissue distribution of multiple new human exon 1. J Mol Endocrinol. 2005;35:283–92.
   PubMed Web of Science ®Google Scholar
• Presul E, Schmidt S, Kofler R, Helmberg A. Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J Mol Endocrinol. 2007;38:79–90.
   PubMed Web of Science ®Google Scholar
• Lu NZ, Cidlowski JA. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell. 2005;18: 331–42.
   PubMed Web of Science ®Google Scholar
• Encio IJ, Detera-Wadleigh SD. The genomic structure of the human glucocorticoid receptor. J Biol Chem. 1991;266: 7182–8.
   PubMed Web of Science ®Google Scholar
• de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, . The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol Med. 1996;2:597–607.
   PubMedGoogle Scholar
• Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP. Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun. 2009;381:671–5.
   PubMed Web of Science ®Google Scholar
• Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res. 1995; 55:2727–9.
   Google Scholar
• Moalli PA, Pillay S, Krett NL, Rosen ST. Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Res. 1993;53:3877–9.
   PubMed Web of Science ®Google Scholar
• Ray DW, Davis JR, White A, Clark AJ. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res. 1996;56: 3276–80.
   PubMed Web of Science ®Google Scholar
• Rivers C, Levy A, Hancock J, Lightman S, Norman M. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab. 1999;84:4283–6.
   PubMed Web of Science ®Google Scholar
• Beger C, Gerdes K, Lauten M, Tissing WJ, Fernandez-Munoz I, Schrappe M, . Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol. 2003;122: 245–52.
   PubMedGoogle Scholar
• van Rossum EF, Lamberts SW. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res. 2004;59:333–57.
   PubMedGoogle Scholar
• Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, . A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol. 2001;28:2383–8.
   PubMed Web of Science ®Google Scholar
• Pujols L, Mullol J, Picado C. Alpha and beta glucocorticoid receptors: relevance in airway diseases. Curr Allergy Asthma Rep. 2007;7:93–9.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Saag KG, Cutolo M, da Silva JA, Bijlsma JW. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol. 2005;34:14–21.
   PubMed Web of Science ®Google Scholar
• Rogler G, Meinel A, Lingauer A, Michl J, Zietz B, Gross V, . Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest. 1999;29:330–6.
   Google Scholar
• Flood L, Lofberg R, Stierna P, Wikstrom AC. Glucocorticoid receptor mRNA in patients with ulcerative colitis: a study of responders and nonresponders to glucocorticosteroid therapy. Inflamm Bowel Dis. 2001;7:202–9.
   PubMed Web of Science ®Google Scholar
• Raddatz D, Middel P, Bockemuhl M, Benohr P, Wissmann C, Schworer H, . Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment Pharmacol Ther. 2004;19:47–61.
   PubMed Web of Science ®Google Scholar
• Geng CD, Vedeckis WV. A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells. Mol Endocrinol. 2011;25:44–57.
   Google Scholar
• Schottelius A, Wedel S, Weltrich R, Rohde W, Buttgereit F, Schreiber S, . Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol. 2000;95:1994–9.
   PubMed Web of Science ®Google Scholar
• Shimada T, Hiwatashi N, Yamazaki H, Kinouchi Y, Toyota T. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis. Dis Colon Rectum. 1997;40(Suppl 10):S54–8.
   Google Scholar
• Kino T, Su YA, Chrousos GP. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci. 2009;66:3435–48.
   PubMed Web of Science ®Google Scholar
• Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, . Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 2000;118:859–66.
   PubMed Web of Science ®Google Scholar
• Orii F, Ashida T, Nomura M, Maemoto A, Fujiki T, Ayabe T, . Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD. Biochem Biophys Res Commun. 2002;296:1286–94.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ouyang Q, Wen ZH, Fiocchi C, Liu WP, Chen DY, . Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World J Gastroenterol. 2005;11:1775–8.
   PubMed Web of Science ®Google Scholar
• Towers R, Naftali T, Gabay G, Carlebach M, Klein A, Novis B. High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. Clin Exp Immunol. 2005;141:357–62.
   PubMed Web of Science ®Google Scholar
• Fujishima S, Takeda H, Kawata S, Yamakawa M. The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients. Clin Immunol. 2009;133:208–17.
   PubMed Web of Science ®Google Scholar
• Hausmann M, Herfarth H, Scholmerich J, Rogler G. Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD. Gut. 2007;56:1328–9.
   PubMed Web of Science ®Google Scholar
• Hori T, Watanabe K, Miyaoka M, Moriyasu F, Onda K, Hirano T, . Expression of mRNA for glucocorticoid receptors in peripheral blood mononuclear cells of patients with Crohn's disease. J Gastroenterol Hepatol. 2002;17:1070–7.
   PubMed Web of Science ®Google Scholar
• De Iudicibus S, Stocco G, Martelossi S, Drigo I, Norbedo S, Lionetti P, . Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. Gut. 2007; 56:1319–20.
   PubMed Web of Science ®Google Scholar
• Mwinyi J, Wenger C, Eloranta JJ, Kullak-Ublick GA. Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J Gastroenterol. 2010;16:3888–96.
   PubMed Web of Science ®Google Scholar
• Sanchez R, Levy E, Costea F, Sinnett D. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol. 2009;15: 3776–82.
   PubMed Web of Science ®Google Scholar
• Vihinen MK, Raivio T, Verkasalo M, Janne OA, Kolho KL. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease. J Clin Gastroenterol. 2008;42: 1017–24.
   PubMed Web of Science ®Google Scholar
• Raivio T, Palvimo JJ, Kannisto S, Voutilainen R, Janne OA. Transactivation assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol Metab. 2002; 87:3740–4.
   PubMed Web of Science ®Google Scholar
• Turner D, Kolho KL, Mack DR, Raivio T, Leleiko N, Crandall W, . Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis. Inflamm Bowel Dis. 2010;16:469–73.
   Google Scholar
• Vihinen MK, Kolho KL, Janne OA, Andersson S, Raivio T. Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009; 48:504–6.
   Google Scholar
• Rintamaki H, Salo HM, Vaarala O, Kolho KL. New means to monitor the effect of glucocorticoid therapy in children. World J Gastroenterol. 2010;16:1104–9.
   PubMed Web of Science ®Google Scholar
• Rintamaki H, Sipponen T, Salo HM, Vaarala O, Kolho KL. Serum immune-activation potency and response to anti-TNF-alpha therapy in Crohn's disease. World J Gastroenterol. 2010;16:5845–51.
   PubMed Web of Science ®Google Scholar
• Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol. 1999;34:66–74.
   PubMed Web of Science ®Google Scholar
• Cucchiara S, Latiano A, Palmieri O, Canani RB, D’Inca R, Guariso G, . Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;44:171–9.
   PubMed Web of Science ®Google Scholar
• Creed TJ, Lee RW, Newcomb PV, di Mambro AJ, Raju M, Dayan CM. The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone. J Immunol. 2009;183:164–71.
   PubMed Web of Science ®Google Scholar
• Smith MA, Marinaki AM, Sanderson JD. Pharmacogenomics in the treatment of inflammatory bowel disease. Pharmacogenomics. 2010;11:421–37.
   PubMed Web of Science ®Google Scholar
• Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol. 2005;17:547–57.
   PubMedGoogle Scholar
• Löwenberg M, Scheffer M, Verhaar A, Peppelenbosch M, Hommes D. A role for STAT5 in steroid-resistant UC? Inflamm Bowel Dis. 2006;12:665.
   Google Scholar
• Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut. 1999;45:382–8.
   PubMed Web of Science ®Google Scholar
• Franchimont D, Louis E, Dupont P, Vrindts-Gevaert Y, Dewe W, Chrousos G, . Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures. Dig Dis Sci. 1999;44:1208–15.
   Google Scholar
• Jinno Y, Ohtani H, Nakamura S, Oki M, Maeda K, Fukushima K, . Infiltration of CD19 + plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis. Virchows Arch. 2006;448:412–21.
   Google Scholar
• Nakahara S, Arimura Y, Saito K, Goto A, Motoya S, Shinomura Y, . Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory bowel disease in Japan. Dis Colon Rectum. 2008;51:598–603.
   Google Scholar
• Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, . Development and evaluation of a Pediatric Ulcerative Colitis Activity Index (PUCAI): A prospective multicenter study. Gastroenterology. 2007; 133:423–32.
   PubMed Web of Science ®Google Scholar
• Seo M, Okada M, Yao T, Matake H, Maeda K. Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol. 2002;37:29–34.
   PubMed Web of Science ®Google Scholar
• Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, . Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19:1079–87.
   PubMed Web of Science ®Google Scholar
• Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, . Predicting outcome in severe ulcerative colitis. Gut. 1996;38:905–10.
   PubMed Web of Science ®Google Scholar
• Lindgren SC, Flood LM, Kilander AF, Löfberg R, Persson TB, Sjödahl RI. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol. 1998; 10:831–5.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373:1905–17.
   PubMed Web of Science ®Google Scholar
• Kabakchiev B, Turner D, Hyams J, Mack D, Leleiko N, Crandall W, . Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis. PLoS One. 2010;5: pii: e13085.
   Google Scholar
• Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 2010;75:1–12.
   PubMed Web of Science ®Google Scholar